Therapeutic potential of nucleotides in the eye
- 1 January 2001
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 52 (1-2) , 190-195
- https://doi.org/10.1002/ddr.1115
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Purinergic cation channels in neurons of rabbit vesical parasympathetic gangliaNeuroscience Letters, 1996
- An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal.Proceedings of the National Academy of Sciences, 1996
- P2-Purinergic Receptors: Subtype-Associated Signaling Responses and StructureAnnual Review of Pharmacology and Toxicology, 1995
- ATP responses in the embryo chick ciliary ganglion cellsNeuroscience, 1995
- ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.The Journal of Physiology, 1994
- Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypesDrug Development Research, 1994
- Modulation of Intraocular Pressure by Adenosine AgonistsJournal of Ocular Pharmacology and Therapeutics, 1994
- Production of Adenosine from Extracellular ATP at the Striatal Cholinergic SynapseJournal of Neurochemistry, 1993
- PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responsesEuropean Journal of Pharmacology, 1992
- Stimulation of cholinergic nerves in dog intestine by adenine nucleotidesEuropean Journal of Pharmacology, 1980